J Clin Invest. 2020 Jun 1;130(6):2800-2802. doi: 10.1172/JCI135794.
Plasmodium vivax bench research greatly lags behind Plasmodium falciparum because of an inability to culture in vitro. A century ago, intentionally inducing a malaria infection was a strategy commonly used to cure late-stage syphilis. These controlled human malaria infections were used with expertise and persisted to the end of World War II. While controlled malaria liver-stage infection has been achieved for both P. vivax and P. falciparum, controlled human transmission to mosquitoes falls short for both species. In this issue of the JCI, Collins et al. present groundbreaking work that establishes a system to transmit P. vivax gametocytes from humans to mosquitoes. The authors injected a unique human isolate of P. vivax that reached high gametocyte density within weeks. This study provides a technical advance that will facilitate the study and eradication of the human parasite P. vivax.
由于无法进行体外培养,间日疟原虫的实验室研究大大落后于恶性疟原虫。一个世纪前,故意诱导疟疾感染是一种常用于治疗晚期梅毒的策略。这些经过精心控制的人体疟疾感染一直持续到第二次世界大战结束。虽然已经实现了对间日疟原虫和恶性疟原虫的肝脏期感染的控制,但对于这两个物种,向蚊子传播的控制人类感染都没有成功。在本期 JCI 中,Collins 等人提出了一项开创性的工作,建立了一个从人类向蚊子传播间日疟原虫配子体的系统。作者注射了一种独特的人类间日疟原虫分离株,该分离株在数周内达到了高配子体密度。这项研究提供了一项技术进步,将有助于研究和根除人类寄生虫间日疟原虫。